M
Minerva Neurosciences, Inc. (NERV)
NCM – Real vaqt narxi. Valyuta: USD
3.92
-0.40 (-9.26%)
Yopilishda: Aug 12, 2026, 4:00 PM EDT
3.85
-0.07 (-1.79%)
Bozordan keyin: Aug 12, 2026, 4:41 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
3.92
-0.40 (-9.26%)
Yopilishda: Aug 12, 2026, 4:00 PM EDT
3.85
-0.07 (-1.79%)
Bozordan keyin: Aug 12, 2026, 4:41 PM EDT
Minerva Neurosciences, Inc., klinik bosqichdagi biofarmatsevtika kompaniyasi, markaziy asab tizimi kasalliklarini davolash uchun mahsulot nomzodlarini ishlab chiqish va tijoratlashtirishga qaratilgan. Uning asosiy mahsulot nomzodi roluperidone bo'lib, u shizofreniya bilan og'rigan bemorlarda salbiy simptomlarni davolash uchun 3-bosqich tasdiqlovchi sinovdan o'tmoqda. Minerva Neurosciences, Inc. 2007 yilda tashkil etilgan va Massachusets shtatining Burlington shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Remy Luthringer Ph.D. | Executive Chairman, CEO & Member of Scientific Advisory Board |
| Mr. Frederick W. Ahlholm CPA | Senior VP, CFO & Secretary |
| Mr. James O'Connor | Chief Business Officer & General Counsel |
| Mr. Joseph Reilly | Senior VP & COO |
| Mr. William B. Boni | Vice President of Investor Relations & Corporate Communications |
| Prof. Michael Davidson M.D. | Member of Scientific Advisory Board & Chief Medical Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-08-07 | 10-Q | nerv-20260630.htm |
| 2026-06-04 | 8-K | d57321d8k.htm |
| 2026-05-27 | 8-K | d119518d8k.htm |
| 2026-05-05 | 8-K | d947378d8k.htm |
| 2026-05-05 | 10-Q | nerv-20260331.htm |
| 2026-04-23 | DEFA14A | d109656ddefa14a.htm |
| 2026-04-23 | DEF 14A | d113727ddef14a.htm |
| 2026-04-23 | ARS | d11443dars.pdf |
| 2026-04-10 | PRE 14A | d113727dpre14a.htm |
| 2026-04-06 | 8-K | d41477d8k.htm |